How Zepbound works
Zepbound (Tirzepatide) is the first and only FDA approved medication that activates both GIP and GLP 1 hormone receptors
GLP 1 pathway
Direct appetite suppression through brain signaling
Slowed gastric emptying for prolonged fullness
Significantly reduced daily caloric intake
Zepbound
Tirzepatide
GIP pathway
Enhanced fat metabolism and energy use
Improved tolerability vs GLP 1 alone
Better long term glycemic control
Prescribed and supervised by experts
Required baseline testing
Zepbound (Tirzepatide) is the first and only FDA approved medication that activates both GIP and GLP 1 hormone receptors. These tests ensure safe prescribing.
Assessment of liver and kidney function to ensure safe medication processing
Precise measurement of blood sugar control and insulin resistance levels
Baseline lipid profile and blood pressure monitoring protocols
Clinical results
Zepbound (Tirzepatide) is the first and only FDA approved medication that activates both GIP and GLP 1 hormone receptors.
15mg dose, 72 weeks
91% vs 35% placebo
Visceral fat reduction
Prescribed and supervised by Dr. Gupta
“It feels amazing to have a supportive team that actually listens to me.”
“I was not expecting insurance help. Usually patients are their own advocate, so I was thrilled
Just like I always have, I’m making informed decisions for my health and my body. I’m
